Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways. With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its
Read More
Australian-based Medical Cannabis producer and supplier, Althea Group (ASX: AGH), have announced this morning that their Bristol-based medical clinic site has secured a licence from a UK independent health and social care regulator. The news suggests that medical cannabis is becoming increasingly accepted in the UK as a treatment option for chronic health conditions. Wholly
Read More